Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06922214

VT ART Consortium: Radioablation for Ventricular Tachycardia

VT-ART-P: Ventricular Tachycardia Ablation and RadioTherapy, a Prospective Study

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
52 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The overall objective of the study is to evaluate the efficacy and safety of stereotactic radiation therapy in the non invasive ablation of ventricular tachycardia refractory to any other type treatment.

Detailed description

By agreeing to participate in this study, the patient will undergo an initial evaluation to verify that his or her condition meets the inclusion criteria required for participation. At that visit, * 12-lead ECG will be performed * Echocardiography * CT scan of the chest * Laboratory tests: NT proBNP, HS Troponin I * PMK device evaluation The study will have a duration of 60 months and will involve 52 patients with the same disease from which one is affected. Specifically, the total expected duration of individual subject participation in the study will be 60 months. Participation in the study does not involve any expense for the patient or any compensation. Participation in the study may involve some risks such as :: pericarditis, actinic pneumonia, worsening heart failure, exitus. The following benefits can be expected from participation in this study: reduction of VT episodes compared to the pre-treatment period, reduction/total discontinuation of antiarrhythmic drugs compared to baseline (before radioablation), improvement of cardiac parameters compared to baseline : LVEF, left ventricular end-diastolic volume/diameter, end-systolic volume/diameter, RVEF and TAPSE for right ventricular function, improvement of patient's quality of life (SF-36) compared to baseline. No direct benefits may also emerge from the study, but still significant for research.

Conditions

Interventions

TypeNameDescription
RADIATIONStereotactic Body Radiation Therapy (SBRT)SBRT ( 25 Gy single fractions at isodose 80%) on the area responsible of ventricular tachicardia

Timeline

Start date
2024-11-26
Primary completion
2027-10-31
Completion
2029-10-31
First posted
2025-04-10
Last updated
2025-05-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06922214. Inclusion in this directory is not an endorsement.